Repairon Immuno

Repairon Immuno GmbH is a young startup with the mission to develop novel cell therapies to treat most challenging diseases. To achieve this goal, we will take advantage of exclusively licensed induced Pluripotent Stem Cell (iPSC) line, which is the only iPSC line being currently validated in an European clinical trial. This cell line in combination with our proprietary, scalable, GMP-compliant differentiation platform as well as proprietary gene editing designs will enable us to generate never-done-before types of cell drug products.